Please try another search
3-D Matrix, Ltd. develops self-assembling peptide technology in Japan and internationally. It offers PuraMatrix, a self-assembling peptide hydrogel for use in the regenerative medicine, cell therapy, drug delivery systems, and other uses in various fields. The company was incorporated in 2004 and is based in Tokyo, Japan.
Name | Age | Since | Title |
---|---|---|---|
Kazuharu Tsuboi | 46 | 2015 | Director |
Tomoyuki Arai | 49 | 2007 | Director |
Kazuya Shimamura | 49 | 2012 | Independent External Director |
Jun Okada | 48 | 2007 | President & Representative Director |
Keiji Nagano | 69 | 2004 | Chairman of the Board |
Mamoru Nomura | - | - | Medical, Science and Technology Adviser |
Bengt Norden | - | - | Medical, Science and Technology Adviser |
Yoshiaki Harino | - | - | Medical, Science and Technology Adviser |
Takashi Noguchi | - | - | Medical, Science and Technology Adviser |
Takao Miki | 48 | 2020 | Head of EMEA Business & Director |
Noriyuki Okawara | 54 | 2023 | Outside Auditor |
Ikkei Matsuda | 62 | - | Medical, Science and Technology Adviser |
Robert S. Langer | 75 | - | Medical, Science and Technology Adviser |
Tatsutoshi Nakahata | - | - | Medical, Science and Technology Adviser |
Tsutomu Kawabe | 67 | 2005 | External Full-Time Auditor |
Toshi Amanuma | 49 | 2020 | Director |
Toshihiro Hanyu | 56 | 2023 | Outside Auditor |
Satoru Kobayashi | 44 | 2017 | Head of Business Development & Director |
Ryuhei Mogi | 57 | 2023 | Director |
Are you sure you want to block %USER_NAME%?
By doing so, you and %USER_NAME% will not be able to see any of each other's Investing.com's posts.
%USER_NAME% was successfully added to your Block List
Since you’ve just unblocked this person, you must wait 48 hours before renewing the block.
I feel that this comment is:
Thank You!
Your report has been sent to our moderators for review